Cyclophosphamide/Prednisolone/Rituximab/Vinblastine Regimen

Preferred Label : Cyclophosphamide/Prednisolone/Rituximab/Vinblastine Regimen;

NCIt synonyms : Cyclophosphamide/Vinblastine/Prednisolone Plus Rituximab Regimen; CVbP Rituximab Regimen; Cyclophosphamide-Prednisolone-Rituximab-Vinblastine Regimen; CVbP Plus Rituximab Regimen; Cytoxan/Prednisolone/Rituxan/Vinblastine; Cyclophosphamide/Prednisolone/Rituximab/Vinblastine; Cyclophosphamide-Prednisolone-Rituximab-Vinblastine;

NCIt definition : A regimen consisting of cyclophosphamide, vinblastine, prednisolone and rituximab that may be used in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL).;

NCI Metathesaurus CUI : CL1792789;

Détails

Origin ID

C188174;

UMLS CUI

C5707637;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Prednisolone Acetate [NCIt concept]
- Rituximab [NCIt concept]
- Vinblastine Sulfate [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients